Due to the increased risk for sudden death in infants and young children less than three years of age with PWS polysomnography is recommended in infancy, both prior to growth hormone treatment and monitoring during growth hormone therapy [37,38,49]. The gene discussed is GH1; the disease is Prader-Willi syndrome.